Mounjaro remains unlaunched in Korea as revenue slips Despite picking up Korean approvals for tirzepatide in diabetes and obesityJune 2023 and August 2024, respectivelythe drug, marketed as Mounjaro, still hasnt launched
However, we want to highlight that data collection periods for eCQMs (as for all measures) are not dictated by the Overall Hospital Quality Star Rating but rather by their respective CMS quality program
Dagli N, Kumar S, Ahmad R, Narwaria M, Haque M
These FDA-approved treatments support appetite regulation, enhance fullness, slow digestion and aid metabolic health all important tools when lifestyle changes alone arent enough
How will your treatment be monitored for effectiveness and safety
This change promotes the binding of RNA polymerase II and basal transcription factors to the open DNA to initiate transcription, involving anti-inflammatory cytokines, such as IL-10 and dual specificity phosphatase 1 (DUSP1) [25]